Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan vs Esomeprazole for Erosive Esophagitis Revisits
NCT04720781Completed
- Sponsor
- Showa Inan General Hospital
- Start
- Jan 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of vonoprazan in erosive esophagitis (EE) (2 arms), sponsored by Showa Inan General Hospital. Primary endpoint: Number of patients who revisit outpatient clinic without appointments at 3 months. Started Jan 2021; status: completed.
02
Drugs
vonoprazan
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on NCT04720781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04720781.